2. Defination
Inflamation of lung parenchyma
CAP is defined as an acute infection of the pulmonary paranchyma in a
patient who has acquired the infection in community,as distinguished
from HAP. It occurs within 48 hours of hospitalization or in patient
presenting with pneumonia who does not have any characteristics of
HCAP
Health care associated pneumonia: Pneumonia acquired in healthcare
facility such as nursing homes haemodialysis center and out patient
clinics or hospitalization within past,received parental
antibiotic,chemotherapy within past 3 months(pneumonia in
nonhospitalized patient who have significant experience with healthcare
system.)
Hospital acquired pneumonia: pneumonia that occurs 48 hours or more
after hospital admission and that was not present at time of admission
VAP:pneumonia that occurs 48 hours or more after endotracheal
intubation
3.
4. Etiology
Agents include bacteria,fungi,viruses and protozoa
New pathogens:hantavirus,metapneumovirus,
coronavirus and community acquired strains of methicilline
resistant staphylococcus aureus(MRSA)
5.
6.
7.
8. pathology
Congestion: affected lobe boggy and red,vascular
congestion seen with many neutrophils and proteinaceous
fluid many bacteria in alveoili
Red hepatization: alveolar cell packed with
RBCS,neutrophills and fibrin
Gray hepatization: red cells are lysed fibrinosuppurative
exudate persist
Resolution:in uncomplicated case exudates are digested
by enzymes produce semisolid debris which is coughed
up or ingested by macrophage
9. Risk factors
CHF
Smoking ,tobaco,COPD
HIV
Diabetes
Patient with splenectomy
Immunocompromised
Alcohol consumption
Hypoxemia
Acidosis
Malnutrition
Dysphagia
Alteration in level of consciousness-microaspiration of stomach
content
Acid reducing agent proton pump inhiitors and h2 blocker
Antipsychotic drug
10. Signs and symptoms
Typical pneumonia
Febrile with tachycardia
h/o chills and/or sweats
Cough
Shortness of breath may or
may not be
Pleuritic chest pain
GI symptomos
nausea,vomiting,and/or
diarrhea other
fatigue,headache,mylgia
and arthralgia
Atypical pneumonia
Gradual and insidious onset
Low grade fever
Dry cough no blood tinge
Moderate amount of sputum
Moderate elevation of wbc
Moderate sign of cosolidation
There may be respiratory
distress out of proportion to the
physical and respiratory finding
11. Streptococus pneumonia
Streptococcus most common organisum causing CAP
increased frequency inthree subsets of patients: (1) those
with underlying chronicdiseases such as CHF, COPD, or
diabetes;
(2) those with either congenital or acquired immunoglobulin
defects (e.g.,with the acquired immune deficiency syndrome
[AIDS]);and
(3) those with decreased or absent splenic function(e.g.,
sickle cell disease or after splenectomy).
12. Hemophillus influenzae
• Both encapsulated and unencapsulated forms are
important causes of community-acquired pneumonias. The
former can cause a particularly life-threatening form of
pneumonia in children, often after a respiratory viral
infection.
• Adults at risk for developing infections include those with
chronic pulmonary diseases such as chronic
bronchitis,cystic fibrosis.common cause of acute
exacerbation of COPD
13. Staphylococcus aureus
• S. aureus is an important cause of secondary bacterial
pneumonia in children and healthy adults after viral
respiratory illnesses (e.g., measles in children and
influenza in both children and adults)
high incidence of complications,: lung abscess and
empyema.
• Staphylococcal pneumonia occurring in association
with right-sided staphylococcal endocarditis is a
serious complication of IV drug abuse
• It is also an important cause of nosocomial
pneumonia
14. Klebsiella pneumonia
K. pneumoniae is the most frequent cause of gram negative
bacterial pneumonia
Klebsiella-related pneumonia frequently affects debilitated
and malnourished persons, particularly chronic alcoholics.
• Thick and gelatinous sputum is characteristic, because the
organism produces an abundant viscid capsular
polysaccharide, which the patient may have difficulty
coughing up.
15. Pseudomonas pneumonia
Pseudomonas pneumonia also is common in persons
who are neutropenic, usually secondary to
chemotherapy; in victims of extensive burns; and in
patients requiring mechanical ventilation
P. aeruginosa has a propensity to invade blood vessels
at the site of infection, with consequent extrapulmonary
spread; Pseudomonas bacteremia is a fulminant
disease,
Histologic examination reveals coagulative necrosis of
the pulmonary parenchyma with organisms invading
the walls of necrotic blood vessels (Pseudomonas
vasculitis).
16. Moraxella Catarrhalis
M. catarrhalis is being increasingly recognized as a cause of
bacterial pneumonia, especially in elderly persons.
• It is the second most common bacterial cause of acute
exacerbation of COPD in adults.
• Along with S. pneumoniae and H. influenzae, M.
Catarrhalis constitutes one of the three most common
causes of otitis media in children
17. Legionella pneumonia
L. pneumophila flourishes in artificial aquatic environments,such as water-
cooling towers and within the tubing system of domestic (potable) water
supplies.
The mode of transmission : either inhalation of aerosolized organisms or
aspiration of contaminated drinking water.
Legionella pneumonia is common in persons with some predisposing
condition such as cardiac, renal, immunologic,or hematologic disease.
Organ transplant recipients are particularly susceptible.
Rapid diagnosis is facilitated by demonstration of Legionell aantigens in the
urine or by a positive fluorescent antibody test on sputum samples; culture
remains the standard diagnostic modality. PCR-based tests can be used on
bronchial secretions in atypical cases.
20. Diagnostic approach
Chest xray
Sputum examination
Blood culture sensitivity: high risk patient as neutropenic,
asplenia,complement deficiency,CLD or severe CAP
Antigen test: for pneumococcal and certain legionella
antigen in urine
PCR: detect neucleic acid of legionella spp., M.pneumonia
21.
22.
23.
24.
25.
26. Expectorated sputum sample are
recommended for hospitalized
patients
Icu addmission
Failure of antibiotic therapy
Cavity lesion
Active alcohol abuse
Obstructive or structural lung disease
Immunocompromised host
epidemic
31. complication
Respiratory failure
Shock
Multiorgan failure
Coagulopathy
Exacerbation of comorbid illness
Lung abscess
Complicated pleural effusion
Brain abscess by CA MRSA,p.aeuruginosa,s,pneumoniae
32. Risk factors for drug resistance
Age>65
Beta lactums,macrolide or fluroquinolone
Alcoholism
Immunosuppressive illness or therapy
Exposure to child in daycare center
33. Treatment duration and
response
Most ambulatory patients with CAP should be treated for five
days including those receiving azithromycine 500mg on first
day followed by 250 mg on subsequent day
Pt should be afebrile for >48 hours and clinically stable
before therapy is discontinued.